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A succmct overview of recent results on the biochemistry of extracellular matrix (ECM) is presented. The rapid expansion of this dlsciplme over 
the best decades renders impossible to give an even approximately complete coverage of matrix biology. Some selected results concerning the four 
major families of macromolecules composing the ECM, that is. collagens (I4 types described), elastm(s). proteoglycans and structural glycoproteins 
(especially fibronectin) are described. Special attention is directed to a crucial aspect of matrix biology: cell-matrix interactions. A number of cell 
membrane receptors were recently described mediating the two way information flow from the cells to the matrix via the ‘programme’ of ECM 
synthesis coded in the genome and unfolding during differentiation and from the ECM to the cells through the membrane receptors which contact 
the cytoskeleton. One of them at least, the elastin receptor was shown to be linked through a G-protein-phosphnlipase C-IP3 mediated relay to 
the regulation of intracellular calcium. Modifications of the ECM will therefore influence cell behaviour. Derangements of this informational feed 
back mechanisms appear to be involved in most age-related connectlbe tissue diseases. 
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1. INTRODUCTION 
During the last decade our knowledge about the 
descriptive and molecular biology of extracellular 
matrix (ECM) increased exponentially. An exhaustive 
review of only even recent work in this area would cover 
a whole volume. We have therefore restricted our 
review to selected areas and refer to recent exhaustive 
reviews covering the individual macromolecules of the 
ECM. For didactic purposes the macromolecules 
isolated from a variety of connective tissues (CT) of dif- 
ferent animal species, from invertebrates to humans, 
can be arranged in four major categories or families: (i) 
collagens, (ii) elastin(s), (iii) proteoglycans (PG) and 
(iv) structural (or connective tissue (CT)) glycoproteins 
(SGP). The first two families form the fibrous scaf- 
folding of CTs, the PGs and SGPs, the ‘filling’ of the 
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interstices and the interfaces between cells and ECM. 
We shall mention a few aspects of recent work carried 
out on these substances and focus on some of those 
results which appear to be the most important for the 
relationship between the structure and function of CTs. 
2. COLLAGENS 
Fourteen different collagen types are recorded today 
and there is no reason to believe that this is the final 
number [l-4]. The classical triple helix represents a 
quantitatively more or less important but functionally 
essential part of these molecules as shown schematically 
in Fig. 1. For the major fibrous collagens, types 1, II 
and III (see Kiihn in [2]), the relatively rigid triple helix 
represents the major part of the molecule. For type VI 
collagen more than half of its molecular weight is 
represented by non-triple helicoidal, glycoprotein-like 
structures (Timpl in [2,5]). Type IV collagen, the major 
constituent of basement membranes, discussed in detail 
by K. Kiihn at the Budapest FEBS-meeting, forms a 
lamellar ‘chicken wire’-like structure as suggested from 
structural and sequence studies [6-IO]. 
The primary sequence of the o(l(IV) and (YZ(IV) chains 
were deduced from protein chemical studies and cDNA 
sequencing. The a2(IV) chain contains an excess of 43 
amino acid residues, 21 of them form a disulfide- 
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Fig. 1. Schematic representation f 12 out of the 14 known collagen 
molecules. The triple helical portions are represented asrods, the non- 
triple helical portions, mostly glycoprotein-like parts as globules or 
differently shaped extremities. Interruption of the triple helix is also 
indicated by vertical bars (i.e. for collagen type IV). (Acc. to P. Kern 
and [3].) 
bridged loop, a unique structure in the collagen family 
[10]. The c~(IV) chain contains 21 non-triplet interrup- 
tions of the collagenous domain [6]. The mode of ag- 
gregation of the non-collagenous NCl and NC2 do- 
mains, the disulfur stabilisation of the 7 S domain 
enabled Ktihn et al. to propose a detailed structure of 
the interacting ends of vicinal collagen IV molecules 
during polymer formation. The folding of collagen IV 
was studied in isolated dimers and starts from the C- 
terminus (NC1 domain) to proceed towards the N- 
terminus. The triple helix formed in a zipper-like 
fashion, the integrity of NCl being essential for nuclea- 
tion [9]. A special arrangement of disulfide bonds gives 
a peculiar clover leaf-like structure to this NCl-region 
[8]. The sequencing of the genes coding for the cq(IV) 
and c~2(IV) chains revealed the existence of a common 
promoter egion situated between these two genes. This 
is an original and efficient way to coordinate their 
transcription and synthesis with a promoter acting 
upstream and downstream [11,12]. These remarkable 
studies showed the great complexity of the structure of 
this functionally highly important collagen. 
Type VII collagen, forming loosely bonded fibrous 
structures was identified with the anchoring fibrils of 
the dermo-epidermal junction [2]. Type IX collagen, 
occurring together with type X and XI in cartilage, was 
shown to bear a single glycosaminoglycan (GAG) 
chain, further blurring the once so clearly defined limits 
between the CT-macromolecules. 
Relatively little is known on the function of the most 
recently identified collagen types. Although the use of 
probes enabled the identification in genomic libraries of 
repeating sequences of the typical Gly-x-y triplets 
characteristic of the collagenous triple helix, the further 
identification and functional study of newly identified 
molecules depends on phenomenological experiments 
using cell or tissue cultures and also on the skillful ex- 
ploitation of pathological models. A good example of 
this is the identification of mutations or deletions in the 
genes of collagen type I in most cases of osteogenesis 
imperfecta [13]. 
The phylogenetic analysis of the collagen families 
was further advanced by Garrone's team who pioneered 
studies with sponge cells and showed the presence of 
several different genes coding for collagen a-chains at 
this earliest stage of phylogenetic appearance of col- 
lagens [14]. These phylogenetic studies confirmed the 
original proposition concerning the importance of the 
54 kb elementary exon structure coding for the triple 
helical portions from at the beginning of the evolution 
of genes coding for collagen c~-chains. The sponge col- 
lagen genes appear to code also for non-fibrillary col- 
lagen structures similar to type IV and earthworm 
cuticular collagens [14/a]. 
Collagens, as other matrix macromolecules, how 
conspicuous changes with aging. Verzar attributed the 
increasing thermal stability and resistance to col- 
lagenase of aging collagen fibers to increasing crosslink- 
ing [15]. The identification of lysine-derived crosslinks 
suggested more qualitative than quantitative modifica- 
tions [16]. According to recent studies on the non- 
enzymatic glycation of proteins it appears probable that 
the Maillard reaction between reducing sugars and pro- 
tein amino groups may well be responsible for this 'ag- 
ing' of collagen [17]. This reaction which concerns 
several other proteins of the organism, is accelerated in
diabetics and may well play an important role in the 
development of micro- and macro-angiopathies. 
As far as the tissue localization of the different ypes 
of collagens is concerned, the use of monoclonal an- 
tibodies turned out to be a valuable tool. It showed, 
among others, the wide-spread occurrence of type VI 
collagen, present in many tissues [4,5,18]. 
The regulation of the biosynthesis of the different col- 
lagen types is still only partially understood, as is the 
regulation of fiber diameter and orientation [1-4]. 
Using explant cultures of bovine corneal stroma, it 
could be shown that besides collagen type I (75% of 
total hypro), they also contain collagens type V (8%) 
and VI (17070) in appreciable proportions [19,20]. Pulse- 
chase experiments suggested a half-life of 36 h for type 
I, 10 h for type V and of 6 h for type VI collagen in this 
tissue [20]. Ultrastructural studies indicate a close 
association of type I and type VI fibers, the latter pro- 
bably playing an important role in the regulation of 
fiber diameter and orientation. The regulation of the 
coordinated synthesis of these collagens which results 
during embryonal development in the formation of the 
transparent stroma, cannot be repeated uring wound 
healing in the adult animal. This results in a loss of 
capacity of keratocytes to reestablish the original highly 
organized fibrous diffraction pattern and in the loss of 
transparency of wounded corneas [21]. The recent 
original hypothesis of Fleishmajer et al. [22] tends to ex- 
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plain fiber width regulation by the differential and 
delayed loss of the C and N propeptides of types I and 
III pro-collagens. The presence of these propcptides 
during the association of the freshly extruded molecules 
with the growing fiber would be a guide for their lateral 
apposition (N-propeptides) and also a stop sign in- 
hibiting further increase in fiber diameter (C- 
propeptide). 
There appear to exist also long-term regulatory 
mechanisms as shown by the progressive increase of the 
type III over type I + III collagen ratio in several con- 
nective tissues with chronological aging [23]. In some 
aging diseases such as diabetes and also as a result of in- 
tensive UV treatment of the skin, this increase is ac- 
celerated, together with an increase of fibronectin (FN) 
biosynthesis [24]. Low molecular weight heparin 
fragments could correct this by selectively decreasing 
collagen III and FN biosynthesis [25,26]. 
Mention should also be made of the collagen triple 
helical sequences identified in unrelated molecules such 
as the acetylcholine receptor, the Clq component of 
complement and the scavenger receptor of macro- 
phages involved in the uptake of modified (oxidized, 
acetylated) LDL j1,27]. These examples show that 
genomic sequences coding for the triple helical portions 
of collagens were efficiently used for the anchoring of 
other molecules in cell membranes. 
Little is known yet of the factors stabilizing the 
phenotype of collagen biosynthesis of differentiated 
cells. Chondrocytes for instance express collagens type 
II together with type IX, X and XI in smaller amounts. 
During the in vitro cultivation this phenotype is rapidly 
lost and collagen type I becomes predominant [4]. A 
similar shift in phenotype appears to occur in osteoar- 
thritic cartilage. Cytokines such as IL-1 may play a role 
in this process as well as in the triggering of cartilage 
degradation 1281. 
3. ELASTIN(S) 
Elastin is phylogenetically speaking the youngest 
matrix macromolecule, appearing in its present form 
only in vertebrates [29,30]. The mature elastic fibers ex- 
hibit a rubber-like (entropy-driven) elasticity. Its excep- 
tional physical and chemical resistance (as, for instance, 
to boiling in 0.1 N NaOH) was attributed to the hydro- 
phobic interactions stabilizing its tertiary (and quater- 
nary) structure. This explains also its strong affinity for 
Iipids and calcium. Their deposition in the mature 
fibers during aging and atheroscferosis leads to a pro- 
gressive loss of elasticity and degradation by elastase- 
type proteases. The biosynthetic precursor of elastic 
fibers, tropoelastin, was first isolated from porcine aor- 
tas of animals raised on a copper-free diet and partially 
sequenced by Sandberg and associates [31]. The gene 
coding for tropoelastins of several species were se- 
quenced [32-341. The presumably single copy gene (per 
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hapIoid genome) of about 40 kb situated on the long 
arm of chromosome 2 in humans, has one of the highest 
intron/exon ratios (1S:l). The exons are arranged in a 
cassette-like fashion coding for hydrophobic or 
~rossl~nking domains 1361. Exon 36 at the 3’-end codes 
for a large untranslated region and 13 highly conserved 
C-terminal amino acids. There are several differences 
between the genes of human, bovine and other species 
investigated [36]. The 5’ flanking region contains GPl 
and API binding sites and a CAAT box but there is no 
TATA box in the promoter region. The human gene can 
use at least 7 different initiation sites. The resemblance 
of the elastin gene to other constituti~~ely expressed 
genes is surprising because of its rather precise 
spatiotemporal expression. At least 10 bovine and 6 
human exons were shown to be alternatively spliced in 
a non-randomly coordinated and developmentally 
regulated fashion [36]. Accordingly, 6 bovine and 11 
human mRNAs have been characterized and at least 3 
tropoelastin translation products can be seen on con- 
ventional PAGE. 
The elastic fibers are associated with ‘microfibrillar’ 
structures composed of several glycoproteins 1371. The 
last identified high molecular weight glycoprotein ap- 
parentty associated with elastic fibers is fibrillin [38]. 
There is no definitive agreement on the number and 
proportion of the different glycoproteins present in 
these microfibriliar structures [37]. 
The regulation of tropoelastin biosynthesis has been 
studied by several investigators. Several different 
spIisomers can be identified in mesenchymal cell cul- 
tures (arterial smooth muscle ceils, fibroblasts, chon- 
drocytes) by immunoblots. Using fibroblast cultures 
from bovine ligamentum nuchae Mecham’s team could 
show that the initiation of tropoelastin biosynthesis is 
developmentally regulated [397. When elastin synthesis 
starts, the fibroblasts become chemotactic to elastin 
peptides. Fibroblasts in culture, although actively pro- 
ducing tropoelastin, could not incorporate it into 
crosslinked insoluble elastic fibers. In explant cultures, 
however, active incorporation of soluble precursors 
occurred into fibrous elastin [40]. Elastin production 
declined with age and with increasing population 
doublings. Similar results were found by Davidson’s 
team using human skin fibroblasts [41,42]. Maximal 
synthesis occurs at early confluency (32-49x 10’ 
molecules/cell/h}, increased linearly up to 72 h (in the 
presence of serum) and was insensitive to inhibition of 
crosslinking. BiosyIlthesis declined after 30 population 
doubiings and also above 70 years of age. In some cutis 
laxa patients a marked reduction of tropoelastin pro- 
duction was found in fibroblast cultures from skin 
biopsies, apparently because of a modification of 
pretranslational control [42]. Smooth muscle cells from 
aorta produce also large amounts of tropoelastin in cell 
culture and are able to crosslink it and deposit fibrous 
elastin resulting (in some species such as the rat) in 
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layered cell-matrix formation [43]. Kagan’s laboratory 
studied peptidyl lysyloxidase catalysing t,he crosslinking 
of tropoelastin during fiber formation f44f and describ- 
ed many properties of this crucially important enzyme. 
Recent progress in efastin biochemistry has come 
from the study of cell-elastin interactions. An adhesion 
mechanism enables mesenchymal cells (fibroblasts, 
smooth muscle cells) [45,463 and also highly metastatic 
malignant cells [47,48] to adhere strongly to the elastic 
fibers. The isolation of the adhesive complex from 
metabolically labelled fibroblasts suggested a role for a 
120 kDa glycoprotein designated as elastonectin 14.51, 
Its synthesis and cell-fiber adhesion could be ‘induced’ 
by the previous addition of soluble elastin peptides (K- 
elastin) suggesting a receptor mediated mechanism 
[45,46,48]. The existence of a receptor recognising 
eiastin-specific sequences was also suggested by 
modifications of ion-fluxes in cells in presence of elastin 
peptides (increased calcium influx, decrease of ouabain- 
dependent K i influx) as well as the liberation of oxygen 
radicals and lytic enzymes (elastase) from human white 
blood celis 149-5 If = I~dependentI~ Mecham’s team also 
arrived at the conclusion that the chemotactic effects of 
eiastin peptides are mediated by an elastin receptor 
[52-541. It could be shown that the activation of this 
receptor is mediated by a G-protein, IP3 and RAG pro- 
duction and could be blocked by the appropriate in- 
hibitors [55,56], abolishing Ca2* influx and the induc- 
tion of adhesion. Non-induced adhesion was, however, 
not inhibited. The ligand-specific subunit of the elastin 
receptor is a 65-67 kDa iectin-like protein sensitive to 
lactose 152-541 which was shown recently to cross-react 
with laminin-sequences 1541. Neither lactose nor RGD- 
peptides could, however, inhibit non-induced adhesion 
of cells to elastic fibers. The expression of the elastin 
receptor and of the adhesive mechanism by highly 
metastatic (but not by low metastatic) tumor cells 
14’7,481 suggests a possible role for these mechanisms in 
the colonisation of elastin-rich tissues (lung) by such 
cells. 
Progress has also been made in the characterisation 
of elastase-type proteases [57,58]. These enzymes 
beibng to severaf different classes of proteases and are 
produced by a variety of cells. Their importance in 
several pathological processes (emphysema, aneurysm 
formation, athero-arteriosclerosis, inflammation, etc.) 
was demonstrated by several laboratories. Synthetic 
and natural elastase inhibitors are actively being in- 
vestigated in the hope of their therapeutic efficiency in 
the above diseases [30]. 
4. PROTEOGLYCANS 
Designated for a long time as acid mucopolysac- 
charides, these compounds were considered as rich in 
carbohydrates until moIecular genetic methods together 
with tedious isolation procedures enabled the recogni- 
tion of a variety of backbone proteins onto which the 
glycosaminoglycan chains were linked. The car- 
bohydrate chains of proteoglycans (PG) were among 
the first well-characterized ECM components (for a 
review see f59,60]) which show a striking regularity of 
repeating sequences containing hexosamines and uranic 
acids (D-glucosamine, D-galaotosamine, D-glucuronic 
acid, L-iduronic acid), N-acetylated sometimes N- 
sulfated and U-sulfated on the hexosamine sometimes 
on the iduronic acid moiety. The linkage to the protein 
portion can be (mostly) O- or (sometimes) N-glycosidic 
with an ordered sequence of carbohydrates at the 
linkage point such as Ser(Thr)-Xyl-Gal-Gal-Uron- 
(disach), [59,60]. The only exception remained 
hyaluronate or hyaluronan as designated by Laurent 
and Balazs @I] with its much higher molecular weight 
(in the IOh) and the absence of covalently linked protein 
partner. Besides the carbohydrate-rich cartilage PGs 
there are others with a much lower carbohydrate-to- 
protein ratio such as dermatan-sulfate-PG of the skin, 
for instance. The recognition of heparan-sulfate and 
chondroitin-sulfate PGs on cell membranes and base- 
ment membranes also highlighted the importance of the 
protein portion for membrane insertion and specific in- 
teraction purposes. Finally the recognition of specific 
amino acid sequences commanding the anchorage of 
the glycosaminoglycan chains essentially through the 
work of Ruoslahti’s team [62] definitely focused atten- 
tion on these long-neglected partners of the GAG- 
chains. As only the protein backbone can be directly en- 
coded in the genome, it became logical to propose a 
novel nomenclature for the PGs as was done recently by 
Ruoslahti j&2], based entirely on the specific protein 
partner. In his recent review he enumerates 15 different 
sequenced (mostly by the cDNA) core proteins contain- 
ing GAG chains of the CS, DS, HS or KS type. Among 
the recently identified core proteins one can find 
representatives of the collagen family (collagen type 
IX), invariant chain, transferrin receptor, throm- 
bomoduIi~. The recently demonstrated role of PGs in 
cell-cell and cell-matrix interactions focused attention 
on the membrane-bound HSPGs. Receptors recognis- 
ing selectively some GAG-chains were postulated 
163,641. The role of tumor cell membrane PGs in 
metastasis formation was rendered pfausibfe by the 
demonstration of a regular shift in DS/CS ratio with 
metastatic capacity in rllabdomyoma cell lines t25,66]. 
Progress was accomplished also in t,he understanding of 
the metabolic regulations of PG synthesis and degrada- 
tion. The degradation by hyaluronidase-type enzymes 
was shown to trigger an increased hyaluronate biosyn- 
thesis in human skin fibroblasts [67]. Hyaluronane syn- 
thetase is a membrane-bound enzyme working in coor- 
dination with a receptor recognising nascent hyaluro- 
nane chains [68]. Besides their role in cell-cell and cell- 
matrix interactions, their function as high molecular 
389 
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weight polyelectrolytes in the control of molecuiar traf- 
fic in the ECM and in ion equilibria is also important 
159-611. KS is the only known GAG where the uronic 
acid residues are substituted by galactose-residues [69]. 
It was suggested by Scott that the availabilitiy of 02 
may well be the limiting regulatory factor in its syn- 
thesis 1701. In tissues where the diffusion of oxygen is 
slow such as the cornea1 stroma or cartilage, the rate- 
limiting step in furnishing UDP-glucuronic acid could 
well be the oxidation of UDP-Glc, favoring the ac- 
cumulation of UDP-Gal by the action of UDP-Glc- 
isomerase. 
An important function of HSPGs is in the 
mairltenance of selective filtration capacity of basement 
membranes. Their decrease with age and especially in 
diabetes is an important factor in the progressive loss of 
that capacity 1711. HSPG was also shown to act as a 
storage site for some growth factors (acidic and basic 
FGF) and to play a role in the regulation of ceil pro- 
liferation. The cieavage of HS-chains from endothelial 
cells and their recognition by receptors on smooth 
muscles cells may well represent one of the regulatory 
mechanisms in SMC-proliferation in the arterial wall 
1721. The interaction properties of PGs depend both on 
the protein and GAG-portions. The core protein of car- 
tilage PGs contains iectin-like domains interacting 
strongly with hyaluronan sequences as well as with link 
proteins [59]. Sulfated GAG chains interact more or 
less specifically with consensus sequences in proteins 
containing basic amino acid cluster (BB X B or BBB XX 
B) [62]. Other more specific interactions necessitate 
specific carbohydrate sequences as the one in heparin- 
antithrombin III interactions [62]. The small and large 
fibroblast PCs, decorin and versican, use also the 
above-mentioned two types of interactions: versican 
contains lectin-like domains as the cartilage PC and 
decorin appears to interact with fibronectin and col- 
lagen through the protein portions [62]. Syndecan, a 
cell membrane PG, exhibits both types of interactions, 
to collagen and fibronectin with the HS and CS GAG- 
chains, membrane anchorage being assured by the core 
protein. The lymphocyte homing receptor, Hermes or 
CD44 carrying CS chains is another example. The 
transrnembrane domain of the core protein is involved 
in the reorganisation of actin filaments. The presence of 
alternating sequences of lectin-like domains, EGF-like 
domains and complement regulatory domains in some 
human receptors also confirms the importance of the 
backbone proteins in the regulation of cell proIiferation 
and interactions [62]. Another type of interaction of 
great physiopathoiogical significance is between some 
PGs and lipoproteins (LDL). These interactions appear 
to be responsible for the deposition of lipids in the 
subintima during atherogenesis [73-763. 
This short and by far not exhaustive enumeration of 
some of the recent aspects of PG-research illustrates the 
considerable progress accomplished since the first 
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characterisation of GAG-chains in CT-extracts by 
Meyer, Dorfman and others [59,60]. 
5. STRUCTURAL GLYCOPROTEINS 
It became clear in the early sixties that besides ‘CO]- 
tagen’, ‘acid mucopolysaccharides’ and elastin there 
were locally synthesized constituents in CT-extracts 
which did not fit in any of these families of 
macromolecules 1771. The first such glycoprotein was 
isolated from the cornea1 stroma and its biosynthesis by 
keratocytes demonstrated by in vitro incorporation ex- 
periments [77]. As the amino acid and carbohydrate 
composition of CT-glycoproteins was similar to plasma 
giycoproteins and quite distinct from that of the other 
CT-constituents, and as they appeared to play a ‘struc- 
tural’ role in ECM, we proposed to designate them as 
‘structural glycoproteins’ [77]. Since the characteriza- 
tion of a score of such glycoproteins (fibronectin, 
laminin, nidogen, thrombospondin, fibriliin and 
others; for a review see [77)) some other designations 
were proposed such as CT-glycoproteins or nectins. As 
far as their biological role is concerned several of them 
were shown to play a crucial role in cell-matrix interac- 
tions. The best understood example is fibronectin. Its 
structure is known both from protein chemical studies 
and from gene sequencing f78-811. Here again alter- 
native splicing was shown by Hynes’s and Barralle’s 
teams to produce a variety of isoforms recognized by 
specific monoclonal antibodies. Some of these isoforms 
are sequentially produced during development and also 
in some pathologica conditions. Fibronectin was 
shown to interact with specific cell nlembrane receptors 
(in~egrins) through a limited sequence of amino acids: 
Arg-Gly-Asp or R-G-D. Ruoslahti’s team identified this 
critical sequence in a number of proteins, some of them, 
but not all can interact with integrins [82,83]. These 
adhesion receptors consist of an ty and a fl subunit, 
severai types of each of them are known. They were 
shown to be involved in a score of important recogni- 
tion phenomena such as, for instance, between platelets 
and fibrinogen, thrombin, collagen and other agonists 
@Z-84] with leucocytes and endotheliaf cells [SS], en- 
dothelial cells and von Willebrand factor and others 
[X2-85]. The CY chain consisting of S-S bound heavy and 
light subunits is specific to the Iigand, the 0 subunit is 
common for severai ligands. Not ail LY subunits are then 
proteolytically processed to heavy and light chains, but 
all seem to share some common features, such as 
calmoduiin-like cation binding sequences on the ex- 
tracellular domain. Some (Y chains contain a 180 amino 
acid insertion homologous with a domain in several col- 
lagen binding proteins [86,87]. The p subunits have an 
extracellular cysteine-rich domain and an intracellular 
tyrosine-phosphoryIation site. The non-covalent in- 
teraction between the cy and 0 subunits is strengthened 
by divalent cations. The cytoplasmic domain of in- 
tegrins interacts with the cytoskeleto~ specifically with 
talin and fibulin [87]. They are therefore capable of 
transmitting signals from the exrracellufar matrix to the 
interior of the cell. At least eleven at: subunits can com- 
bine with seven /3 subunits to yield at Ieast 16 
heterodimers and these numbers are still increasing. 
The Leu Cam ieucocyte receptors also belong to this 
superfamily and mediate adhesion of polymor- 
phonuclears, monocytes and lymphocytes to each other 
and to a complement component, C3bi 1841. The very 
late antigen (VLA) family of lymphocyte receptors has 
also been shown to be part of the.integrin family [SS], 
The deletion or deficiency of a subunit of such receptors 
can be the origin of severe pathological conditions, as, 
for instance, the deficiency in Glanzmanfs throm- 
basthenia of the GP IIb/IIia receptor of platelets [89]. 
There is increasing evidence for an ~mpo~ant role of 
cytoadhesins in developmental phenomena: the posi- 
tion-specific (PS) antigens of ~~o~~~~~~~ are integrins 
f90] and R-G-D peptides were shown to inhibit gastrula- 
tion [9I]. Mutants of both 0: and $ subunits couid be 
related to observed developmental and behavioral 
anomalies in ~ro~o~~~~~ ]90]. The cell adhesion 
molecules ICAM- and ICAM- were shown to act as 
counter receptors for LFA-I (or CD1 I /CDIg), a 
leucocytc receptor. In&grin expression and its up- and 
down-regulation vary with cell type, developmental and 
experimental conditions. The phosphorylation of the 
receptor appears to decrease its interactions both with 
its ligand and the cytoskeieton. [87]. TGFP enhances the 
expression of several integrins and can change their 
specific expression ]92]. These few exampIes clearly if- 
lustrate the ever-increasing complexity and biologicat 
importance of the integrin family, 
Much less is as yet known on receptors re~ogni2in~ 
sequences other than the RGD-type, although evidence 
is accumulating in favor of their importance. Interac- 
tion between fibrobiasts and elastin fibers or peptides 
could not be inhibited with RCD-peptides [93]. 
Laminin and other matrix glycoproteins also were 
shown to contain other recognition sequences [94]. It 
appears therefore that for some time at least matrix- 
recognizing cell membrane receptors will remain in the 
forefront of ECM biochemistry. 
Another important aspect is the transmission of the 
signal from the activated receptor to the cell interior. 
Cell-elastin interaction was shown recently to be 
mediated through the G~~rotei~~phosp~~olipase-~- 
IP~-DAG-PKC-pathway [55,56,93]. 
6. DISCUSSION - CONCLUSIONS 
This rapid survey of the already considerable domain 
of biochemistry and celf biology of ECM can only in- 
dicate the amount of detailed knowledge recently ac- 
cumulated and the manifold directions of research and 
applications. We can try to summarize these many 
Cell Prcgrommeof mottrx Spectfic Matrix 
synthesis 
\ 
COflWiWlS 
/f 
Eiostm 
FnJfecglycaos 
Structural glyco- 
proteins 
Fig. 2. The j~~~r~a~~~na~ feedback loop between the celi which syn- 
thesizes its specific ECW and the acrion of the matrix on the ceH, 
mediated through the necrins and the ceil membrane receptors (in- 
tegrinsj which communicates ‘messages’ coming from the matrix to 
the cell. 
aspects of ongoing research and speculation in a scheme 
(Fig. 2) we iike to cat! the ‘central dogma of matrix 
biology’ _ 
This figure illustrates an informational feedback loop 
which starts with the (developemental~y regulated) 
genetically ‘programmed’ expression of genes coding 
for matrix rna~romol~~~i~es. This program is 
characteristic of the state of differentiation of the cell 
and varies with space and time (aging effects). It has 
qualitative components: the choice by the ceil of genes 
which will be expressed and a quantitat.ive component -
their up- and down~regulatio1~ in time and space, 
Epigenetic factors will then determine the structural 
organi~atiotl of the cell- and tissue-specific ECM. This 
matrix recontacts the cells through the transmembran~ 
receptors (integrins) and mediates the transmission of 
the matrix-born messages to the interior of the cells, 
Thereby modifications of the matrix (due ta a modified 
program of biosynthesis or by external factors, infiam- 
mation, lytic enzymes, . . .) can modify cell behavior. 
In this way the informational feedback loop may 
become a vicious circle, possibly involved in the genesis 
of diseases characterized by modifications of the ECM. 
Diabetes, arteriosclerosis, osteoarthritis, age-dependent 
changes are some examples for these type of 
derangements. 
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